|
|
||||||||
1 Membrane Biology Program and Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, 02115; and 2 Department of Medicine, Medical School, University of Massachusetts, Worcester, Massachusetts 01651
Hereditary hemochromatosis (HHC) is one of the most frequent genetic disorders in humans. In healthy individuals, absorption of iron in the intestine is tightly regulated by cells with the highest iron demand, in particular erythroid precursors. Cloning of intestinal iron transporter proteins provided new insight into mechanisms and regulation of intestinal iron absorption. The aim of this study was to assess whether, in humans, the two transporters are regulated in an iron-dependent manner and whether this regulation is disturbed in HHC. Using quantitative PCR, we measured mRNA expression of divalent cation transporter 1 (DCT1), iron-regulated gene 1 (IREG1), and hephaestin in duodenal biopsy samples of individuals with normal iron levels, iron-deficiency anemia, or iron overload. In controls, we found inverse relationships between the DCT1 splice form containing an iron-responsive element (IRE) and blood hemoglobin, serum transferrin saturation, or ferritin. Subjects with iron-deficiency anemia showed a significant increase in expression of the spliced form, DCT1(IRE) mRNA. Similarly, in subjects homozygous for the C282Y HFE mutation, DCT1(IRE) expression levels remained high despite high serum iron saturation. Furthermore, a significantly increased IREG1 expression was observed. Hephaestin did not exhibit a similar iron-dependent regulation. Our data show that expression levels of human DCT1 mRNA, and to a lesser extent IREG1 mRNA, are regulated in an iron-dependent manner, whereas mRNA of hephaestin is not affected. The lack of appropriate downregulation of apical and basolateral iron transporters in duodenum likely leads to excessive iron absorption in persons with HHC.
hemochromatosis; iron transporter; iron metabolism; regulation; divalent cation transporter; divalent metal transporter; iron regulated gene 1; ferroportin
This article has been cited by other articles:
![]() |
B. Wang, S. N. Schneider, N. Dragin, K. Girijashanker, T. P. Dalton, L. He, M. L. Miller, K. F. Stringer, M. Soleimani, D. D. Richardson, et al. Enhanced cadmium-induced testicular necrosis and renal proximal tubule damage caused by gene-dose increase in a Slc39a8-transgenic mouse line Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1523 - C1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Griffin, D. T. Ward, W. Liu, G. Stewart, I. D. Morris, and C. P. Smith Differential expression of divalent metal transporter DMT1 (Slc11a2) in the spermatogenic epithelium of the developing and adult rat testis Am J Physiol Cell Physiol, January 1, 2005; 288(1): C176 - C184. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Kelleher, E Ryan, S Barrett, M Sweeney, V Byrnes, C O'Keane, and J Crowe Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis Gut, August 1, 2004; 53(8): 1174 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pietrangelo Hereditary Hemochromatosis -- A New Look at an Old Disease N. Engl. J. Med., June 3, 2004; 350(23): 2383 - 2397. [Full Text] [PDF] |
||||
![]() |
D. Barisani, A. Parafioriti, M. T. Bardella, H. Zoller, D. Conte, E. Armiraglio, C. Trovato, R. O. Koch, and G. Weiss Adaptive changes of duodenal iron transport proteins in celiac disease Physiol Genomics, May 19, 2004; 17(3): 316 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
K A Stuart, G J Anderson, D M Frazer, L W Powell, M McCullen, L M Fletcher, and D H G Crawford Duodenal expression of iron transport molecules in untreated haemochromatosis subjects Gut, July 1, 2003; 52(7): 953 - 959. [Abstract] [Full Text] |
||||
![]() |
S. Ludwiczek, E. Aigner, I. Theurl, and G. Weiss Cytokine-mediated regulation of iron transport in human monocytic cells Blood, May 15, 2003; 101(10): 4148 - 4154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Abdel-Rahman, F. K. Johnson, G. Gauthier-Dubois, I. E. Weston, and G. L. Kearns The Bioequivalence of Nizatidine (Axid(R)) in Two Extemporaneously and One Commercially Prepared Oral Liquid Formulations Compared with Capsule J. Clin. Pharmacol., February 1, 2003; 43(2): 148 - 153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |